CoChat

Circulating Activin A predicts survival in cancer patients

Open access
Loumaye, Audrey, de Barsy, Marie, Nachit, Maxime, Lause, Pascale, van Maanen, Aline, Trefois, Pierre, Gruson, Damien, Thissen, Jean‐Paul · 2017 · Journal of Cachexia, Sarcopenia and Muscle
Cited by 79

The DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.

Abstract

Background: Several experimental evidences pinpoint the possible role of Activin A (ActA) as a driver of cancer cachexia. Supporting this hypothesis, we showed recently that human cancer cachexia is associated with high ActA levels. Moreover, ActA levels were correlated with body weight loss and skeletal muscle density, two prognostic factors in cancer patients. Our goal was therefore to investigate the value of ActA to predict survival in cancer patients. Methods: Patients with colorectal or lung cancer were prospectively enrolled at the time of diagnosis or relapse between January 2012 and March 2014. At baseline, patients had clinical, nutritional, and functional assessment. Body composition and skeletal muscle density were measured by CT scan, and plasma ActA concentrations were determined. Overall survival (OS) was analysed since inclusion to 24 months later. Results: Survival data were available for 149 patients out of 152. Patients with high ActA (≥408 pg/mL) had lower OS than those with low levels, regardless the type of cancer (OS in colorectal cancer, 50% vs. 79%, P < 0.05; and in lung cancer, 27% vs. 67%, P = 0.001). The multivariable analysis confirmed the prognostic value of ActA independently of tumour stage or inflammatory markers, particularly in lung cancer. Low muscularity was also an independent prognostic factor. Conclusions: Our study demonstrates that high ActA level is an independent prognosis factor of survival in cancer patients. More than a basic marker of the severity of the neoplastic disease or of the inflammatory process, ActA seems to influence survival by contributing to the development of cachexia and loss of skeletal muscle mass.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/jcsm.12209

Cites

9 of 9 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 9 references

Research works printed but not linked: 39

  1. 10.1016/j.cmet.2012.06.011 · DOI · Paper page
  2. 10.1200/JCO.2012.45.2722 · DOI · Paper page
  3. 10.1016/j.semcdb.2015.09.001 · DOI · Paper page
  4. 10.1677/JOE-08-0549 · DOI · Paper page
  5. 10.1016/j.cell.2010.07.011 · DOI · Paper page
  6. 10.1096/fj.13-245894 · DOI · Paper page
  7. 10.2174/187152210793663810 · DOI · Paper page
  8. 10.1002/ijc.29620 · DOI
  9. 10.1210/jc.81.6.2125 · DOI · Paper page
  10. 10.1016/j.cytogfr.2013.03.003 · DOI
  11. 10.1210/jc.2014-4318 · DOI · Paper page
  12. 10.1093/annonc/mds068 · DOI
  13. 10.1016/j.canlet.2014.10.037 · DOI
  14. 10.18632/oncotarget.7796 · DOI · Paper page
  15. 10.1016/S1470-2045(10)70218-7 · DOI · Paper page
  16. 10.1245/s10434-010-0985-4 · DOI · Paper page
  17. 10.1093/ajcn/82.5.1074 · DOI · Paper page
  18. 10.1093/annonc/mdn537 · DOI · Paper page
  19. 10.1016/S0167-9473(98)00096-6 · DOI · Paper page
  20. MandrekarJN MandrekarSJ ChaSS.Cutpoint determination methods in survival analysis using SAS®. SAS® users group international proceedings 282003.
  21. 10.3390/cancers7010070 · DOI · Paper page
  22. 10.3892/ol.2015.3248 · doi:10.3892/ol.2015.3248
  23. 10.1002/hed.23627 · doi:10.1002/hed.23627
  24. 10.1593/neo.81582 · DOI · Paper page
  25. Wu S, 2015, Activin A as a novel biomarker for colorectal adenocarcinoma in humans, Eur Rev Med Pharmacol Sci, 19, 4371
  26. 10.1136/gut.49.3.409 · DOI · Paper page
  27. 10.1038/icb.2011.12 · DOI
  28. 10.1073/pnas.0705971104 · DOI · Paper page
  29. 10.1530/eje.0.1480559 · DOI · Paper page
  30. 10.1016/j.tem.2012.10.006 · DOI · Paper page
  31. 10.1016/j.clnu.2011.07.010 · DOI
  32. 10.1007/s00520-013-1878-4 · DOI
  33. Yarasheski KE, 2002, Serum myostatin‐immunoreactive protein is increased in 60–92 year old women and men with muscle wasting, J Nutr Health Aging, 6, 343
  34. 10.1152/ajpheart.00200.2011 · DOI · Paper page
  35. 10.1016/j.mce.2008.12.019 · DOI
  36. 10.1093/gerona/glr025 · DOI · Paper page
  37. 10.1530/EJE-12-0512 · DOI
  38. 10.1371/journal.pone.0080454 · DOI
  39. 10.1002/jcsm.12089 · DOI · Paper page

Cited by

See all 79

Metadata

Authors
Loumaye, A., de Barsy, M., Nachit, M., Lause, P., van Maanen, A., Trefois, P., Gruson, D., & Thissen, J.
Venue
Journal of Cachexia, Sarcopenia and Muscle
Publisher
Wiley
Published
2017-07-15
Volume
8
Issue
5
Pages
768-777
ISSN
  • 2190-5991 (ISSN-L)
  • 2190-6009
OpenAlex
W2735619199
Cited by
79
References
9
FWCI
5.32
Type
journal article
Language
en
Open access
gold

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Circulating Activin A predicts survival in cancer patients. https://app.cochat.ai/papers/10.1002/jcsm.12209
The paper
Loumaye, A., de Barsy, M., Nachit, M., Lause, P., van Maanen, A., Trefois, P., Gruson, D., & Thissen, J. (2017). Circulating Activin A predicts survival in cancer patients. Journal of Cachexia, Sarcopenia and Muscle. https://doi.org/10.1002/jcsm.12209

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.